Clinical Trial Update: A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CN202 in adults with locally advanced or metastatic solid tumors or hematologic malignancies (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumor

Drugs mentioned

• CN202

Snippet

Sponsor: Curon Biopharmaceutical (Australia) Co Pty Ltd | Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN